Rosetta Capital
Investor profile
Investment firm
Deals
2
distinct rounds
Companies
2
backed
Active span
2014–2025
12 yrs
Total round €
€71M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| NovImmune | Switzerland | 1 | €60M |
| MISSION Therapeutics | UK | 1 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| NovImmune | Series D+ | €60M | 2014-01 |
| MISSION Therapeutics | Other | €11M | 2025-10 |